Press release
Rheumatology Therapeutics Market
Global Rheumatology Therapeutics Market: SnapshotA rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities has also led to the growth in the market.
A report by Transparency Market Research uncovers after in-depth study that the global rheumatology therapeutics market will rise at a lackluster CAGR of 2.7% from 2017 to 2025 to become worth US$ 52.96 bn by 2025 from US$41.88 bn in 2016.
Read Report Overview:https://www.transparencymarketresearch.com/rheumatology-therapeutics-market.html
Depending upon the drug class, the key segments of the global rheumatology disorder market are disease modifying anti-rheumatic drugs (DMARDs), non-steroidal anti-inflammatory drugs (NSAID’s), corticosteroids, uric acid drugs, etc. The DMARDs, which is a group of medicines or combination of medicines used to treat rheumatic diseases by blocking the inflammation, accounts for maximum shaee in the market at present. They are categorized into two major types - biologic DMARDs and synthetic DMARDs.
The biologic DMARDs are mostly used for the treatment of various rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. The patent expiry of top brands such as Humira, however, is expected to deal a blow to the growth in the segment. Market pundits predict the challenge will eventually be overcome by the wide pipeline of other biologics such as interleukin-6. By rising at a 2.6% CAGR from 2017 to 2025, the segment is projected to pull in a revenue of US$45.06 bn by 2025 from US$35.83 bn in 2016. Azathioprine, cyclophosphamide, cyclosporine, and methotrexate are highly used synthetic DMARDs for the treatment of rheumatic diseases.
Obtain the Brochure of the Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1494
In terms of growth rate, corticosteroids are anticipated to surpass all other segments by clocking a CAGR of 4.4% from 2017 to 2025. Rising at this rate, the segment is projected to pull in a revenue of US$1.22 bn by 2025. Their increasing use in developing countries will likely boost their demand.
Substantial Elderly Population Drives North America Market
From a geographical standpoint, North America accounts for a leading share in the global rheumatology therapeutics market because of a rapid rise in the elderly population, who are afflicted with different types of rheumatology disorders. In addition to that, adoption of biologics and biosimilars products for the treatment of moderate to severe rheumatoid arthritis and well-established healthcare facilities has also provided a major boost to the market in the region. Europe trails North America vis-à-vis market size. In terms of growth rate, however, Asia Pacific is predicted to lead. This is because of the significant proportion of population suffering from rheumatoid arthritis and osteoarthritis, increasing per capita healthcare expenditure and approvals of biosimilars for the treatment of several types of rheumatology disorders.
Perceive the Sample of the Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1494
Prominent companies operating in the global rheumatology therapeutics market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc. etc. accounted for the major share in global rheumatology therapeutics market in 2016. The other global players operating in the market include Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Sanofi, and Takeda Pharmaceutical.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: rakesh@tmr.com
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rheumatology Therapeutics Market here
News-ID: 1562671 • Views: …
More Releases from Transparecny Market Research

Global Microgrid Controller Market Forecast 2024-2034 - Market Size, Drivers, Tr …
The global microgrid controller market is witnessing significant growth as decentralized energy systems gain traction. Microgrid controllers, the nerve centers of microgrids, manage distributed energy resources (DERs), ensuring efficient energy distribution, storage, and consumption. These systems provide resilience, optimize costs, and integrate renewable energy sources like solar and wind into the grid seamlessly.
The market is projected to grow at a robust compound annual growth rate CAGR 12.8 from 2024 to…

Lithium Tantalate Crystal Market to hit USD 790 million by 2027, Says Transparen …
The Lithium Tantalate Crystal Market has been witnessing a substantial surge from 2019 to 2027, attributed to its diverse applications across various industries. Lithium Tantalate (LiTaO3) crystals find extensive usage in electronics, telecommunications, and optoelectronics owing to their exceptional piezoelectric and electro-optic properties.
Lithium Tantalate Crystal market is expected to reach a valuation of US$ 790 million by the end of the forecast period, which spans from 2019 to 2027. Additionally,…

North America Climbing Gym Market Size & Share to Surpass USD 1.9 billion by 203 …
The global North America Climbing Gym Market (سوق التسلق في أمريكا الشمالية) has been sailing through robust waters, witnessing a valuation of US$ 947.7 million in 2022. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 8.5% from 2023 to 2031. By the end of 2031, the industry is expected…

Multi-functional Printer Market is expected to grow at 7.2% of CAGR through 2023 …
The global Multi-functional Printer Market (複合機市場) has been sailing through robust waters, witnessing a valuation of US$ 31.2 billion in 2022. As we set our sights on the horizon, the market is poised to embark on a journey of steady growth, with a projected Compound Annual Growth Rate (CAGR) of 7.2% from 2023 to 2031. By the end of 2031, the industry is expected to anchor at an impressive US$…
More Releases for DMARDs
Rheumatoid Arthritis Treatment Market Set to Reach US$ 79.1 Billion by 2033 - In …
Overview of the Market
The global rheumatoid arthritis (RA) treatment market is witnessing significant growth driven by rising disease prevalence, advances in therapeutics, and increased awareness of early diagnosis and management. In 2022, the market generated revenue of approximately US$ 42.9 billion and is forecasted to expand at a steady compound annual growth rate (CAGR) of 5.7% over the next decade, reaching an estimated valuation of US$ 79.1 billion by 2033.…
Disease-Modifying Antirheumatic Drug Market Forecasted to Reach 7.5% CAGR by 203 …
The global Disease-Modifying Antirheumatic Drug (DMARD) market is set to surge at a Compound Annual Growth Rate (CAGR) of 7.5% from 2022 to 2030, as stated in the recently published report from Dataintelo. This substantial growth is primarily fueled by the rising incidence of rheumatoid arthritis, the increasing geriatric population worldwide, and burgeoning demand for advanced treatment options.
The non-steroidal anti-inflammatory drugs (NSAIDs) segment is predicted to hold a dominant position…
Rheumatoid Arthritis Drugs Market size is projected to reach $62,935 million by …
According to a new report published by Report Ocean, titled, “Rheumatoid Arthritis Drugs Market by Drug Class, Route of Administration, and Sales Channel: Opportunity Analysis and Industry Forecast, 2020–2027,"" the global rheumatoid arthritis drugs market size was valued at $57,929 million in 2019, and is projected to reach $62,935 million by 2027, registering a CAGR of 2.8% from 2020 to 2027.
GET SAMPLE PAGES @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1312
Rheumatoid arthritis disease is an autoimmune…
Janus Kinase Disease-Modifying Antirheumatic Drugs (DMARDs) Inhibitors Market Si …
Janus Kinase Disease-Modifying Antirheumatic Drugs (DMARDs) Inhibitors Market 2019 Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a drug type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
Get Sample Copy of this Report – https://www.orianresearch.com/request-sample/1387696
What You Can Expect From Our Report:
Total Addressable Market [Present…
Rheumatoid Arthritis (RA) Drugs Market Report 2018: Segmentation by Drug Class ( …
Global Rheumatoid Arthritis (RA) Drugs market research report provides company profile for AbbVie, Biogen, Inc., Bristol-Myers Squibb, Celgene Corporation, Celltrion Inc., Johnson & Johnson, MedImmune, LLC, Merck & Co., Inc., Novartis International AG, Takeda Pharmaceutical Company Ltd. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,…
Rheumatoid Arthritis Drug Market Rheumatoid Arthritis Clinical Pipeline Report 2 …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Antirheumatoids: Call of Rheumatoid Arthritis
1.1 Prologue towards Rheumatoid Arthritis
1.2 Obtainable Treatment for Rheumatoid Arthritis
Molecular Mechanism of Antirheumatoids
2.1 Purpose of DMARDs in Rheumatoid Arthritis
2.2 Role of Biological Agents in Rheumatoid Arthritis
2.2.1 TNF- Inhibitors
2.2.2 Interleukin -1 and IL-6 Blockers
Classification of Rheumatoid Arthritis Drugs
3.1…